Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnon-membrane spanning protein tyrosine kinase activity

SRC ITK PTK6 JAK1 BTK YES1 FRK FYN

8.78e-08462488GO:0004715
GeneOntologyMolecularFunctionprotein tyrosine kinase activity

SRC ITK PTK6 JAK1 BTK FLT1 NRG2 YES1 FRK FYN MAP2K7

2.03e-0614524811GO:0004713
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

PI4K2B SRC OBSCN MAP3K12 ITK PTK6 JAK1 PHKA1 PIK3C2B SPHK1 BTK POLN PLK1 FLT1 SGIP1 GNPTAB PAK5 NRG2 CRPPA YES1 CIT FRK ATM POLQ FYN MAP2K7

1.15e-0493824826GO:0016772
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

PI4K2B SRC OBSCN MAP3K12 ITK PTK6 JAK1 PHKA1 PIK3C2B SPHK1 BTK PLK1 FLT1 PAK5 NRG2 YES1 CIT FRK ATM FYN MAP2K7

2.21e-0470924821GO:0016773
GeneOntologyMolecularFunctionCD4 receptor binding

HLA-DRB1 SPG21 FYN

2.90e-04112483GO:0042609
GeneOntologyBiologicalProcesscellular catabolic process

HEXA HGF ACADM SRC BCAT2 ALDH1L1 HMOX1 EPX PHKA1 QSOX1 GLB1 PIK3C2B GGTLC3 GLDC SPHK1 PARL TBC1D12 ABCC2 NOS2 GOT1 DNM2 WDR24 MPST EPM2A VPS39 KYAT1 LGALS8 UGT1A1 VPS13D TIMP4 SNX18 VPS41 LRP1 ATM RUFY4

1.96e-06125324435GO:0044248
GeneOntologyCellularComponentvacuole

HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 TBC1D12 PRMT1 WDR24 FUT10 VPS39 LARS1 CIT FRK CD1D AP5B1 VPS41 LRP1 LRP2 RUFY4

2.83e-0591324526GO:0005773
GeneOntologyCellularComponentlysosome

HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 PRMT1 WDR24 FUT10 VPS39 LARS1 FRK CD1D AP5B1 VPS41 LRP1 LRP2

8.91e-0581124523GO:0005764
GeneOntologyCellularComponentlytic vacuole

HEXA CPPED1 MYO7A USE1 HLA-DRB1 ACP5 SRC CHIT1 PLD3 GLB1 CLN5 CYB5R3 PRMT1 WDR24 FUT10 VPS39 LARS1 FRK CD1D AP5B1 VPS41 LRP1 LRP2

8.91e-0581124523GO:0000323
GeneOntologyCellularComponentlysosomal HOPS complex

VPS39 VPS41

1.37e-0422452GO:1902501
GeneOntologyCellularComponentvacuolar HOPS complex

VPS39 VPS41

1.37e-0422452GO:1902500
GeneOntologyCellularComponentendosome

MON2 PI4K2B HLA-DRB1 SRC PLD3 DYSF SPG21 EHD2 JAK1 SPHK1 TBC1D12 OSBPL6 DNM2 MRC1 FLT1 NEDD4L VPS39 ADAM30 ALS2 ECPAS CD1D AP5B1 SNX18 VPS41 LRP1 LRP2 ASTN1 FYN

2.62e-04116724528GO:0005768
GeneOntologyCellularComponentspine apparatus membrane

CHRNA7 CHRFAM7A

4.07e-0432452GO:0098897
GeneOntologyCellularComponentpostsynaptic specialization, intracellular component

PSD SRC DNM2 YES1 FYN

4.98e-04562455GO:0099091
DomainPROTEIN_KINASE_TYR

SRC OBSCN ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

5.19e-079724210PS00109
DomainTyr_kinase_AS

SRC OBSCN ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

5.19e-079724210IPR008266
DomainTyr_kinase_cat_dom

SRC ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

2.08e-06882429IPR020635
DomainTyrKc

SRC ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

2.08e-06882429SM00219
DomainPkinase_Tyr

SRC MAP3K12 ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

7.07e-0612924210PF07714
DomainSer-Thr/Tyr_kinase_cat_dom

SRC MAP3K12 ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

1.28e-0513824210IPR001245
DomainSH2

SRC ITK PTK6 JAK1 BTK LCP2 YES1 FRK FYN

1.32e-051102429SM00252
DomainSH2

SRC ITK PTK6 JAK1 BTK LCP2 YES1 FRK FYN

1.42e-051112429PS50001
DomainSH2

SRC ITK PTK6 JAK1 BTK LCP2 YES1 FRK FYN

1.53e-051122429IPR000980
Domain-

SRC ITK PTK6 JAK1 BTK LCP2 YES1 FRK FYN

1.53e-0511224293.30.505.10
DomainSH3

MYO7A SRC OBSCN NEB ITK PTK6 BTK EPS8L2 YES1 FRK SNX18 FYN

2.62e-0521624212PS50002
DomainSH3

MYO7A SRC OBSCN NEB ITK PTK6 BTK EPS8L2 YES1 FRK SNX18 FYN

2.62e-0521624212SM00326
DomainSH3_domain

MYO7A SRC OBSCN NEB ITK PTK6 BTK EPS8L2 YES1 FRK SNX18 FYN

3.14e-0522024212IPR001452
DomainSH2

SRC ITK PTK6 BTK LCP2 YES1 FRK FYN

5.07e-051012428PF00017
DomainSH3_1

SRC NEB ITK PTK6 BTK EPS8L2 YES1 FRK SNX18 FYN

5.68e-0516424210PF00018
DomainKinase-like_dom

SRC OBSCN MAP3K12 ITK PTK6 JAK1 PIK3C2B BTK PLK1 DNM2 FLT1 PAK5 YES1 CIT FRK ATM FYN MAP2K7 SOS1

8.81e-0554224219IPR011009
DomainPH_dom-like

PSD MYO7A MYO10 OBSCN ITK JAK1 SBF1 BTK OSBPL6 DNM2 EPS8L2 ECT2L ALS2 CIT ELMO3 SOS1

1.47e-0442624216IPR011993
DomainDNA_polymerase_A

POLN POLQ

1.67e-0422422IPR002298
Domain-

PSD MYO7A MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 EPS8L2 ECT2L ALS2 CIT ELMO3 SOS1

1.88e-04391242152.30.29.30
DomainJmjN

KDM5C KDM5D KDM4D

2.41e-04102423SM00545
DomainJmjN

KDM5C KDM5D KDM4D

2.41e-04102423PF02375
DomainJMJN

KDM5C KDM5D KDM4D

2.41e-04102423PS51183
DomainJmjN

KDM5C KDM5D KDM4D

2.41e-04102423IPR003349
DomainPH

PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1

2.87e-0427824212SM00233
DomainPH_DOMAIN

PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1

2.97e-0427924212PS50003
DomainPH_domain

PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 ALS2 CIT ELMO3 SOS1

3.07e-0428024212IPR001849
DomainDNA-dir_DNA_pol_A_palm_dom

POLN POLQ

4.97e-0432422IPR001098
DomainPOLAc

POLN POLQ

4.97e-0432422SM00482
DomainDNA_pol_A

POLN POLQ

4.97e-0432422PF00476
DomainDNA_POLYMERASE_A

POLN POLQ

4.97e-0432422PS00447
DomainPH

PSD MYO10 OBSCN ITK SBF1 BTK OSBPL6 DNM2 CIT SOS1

8.37e-0422924210PF00169
DomainDUF3377

MMP24 MMP15

9.86e-0442422PF11857
DomainPept_M10A_metallopeptidase_C

MMP24 MMP15

9.86e-0442422IPR021805
DomainLys_sp_deMease-like_dom

KDM5C KDM5D

9.86e-0442422IPR013637
DomainPLU-1

KDM5C KDM5D

9.86e-0442422PF08429
DomainPROTEIN_KINASE_ATP

SRC OBSCN MAP3K12 ITK PTK6 JAK1 BTK PLK1 FLT1 PAK5 YES1 CIT FRK FYN MAP2K7

9.99e-0445924215PS00107
DomainEGF_3

RELN FAT1 HMCN2 C8A NRG2 ADAM30 CELSR3 LRP1 LRP2 ASTN1

1.02e-0323524210PS50026
PathwayPID_FCER1_PATHWAY

ITK SPHK1 BTK LCP2 FYN MAP2K7 SOS1

2.06e-05601997M7
PathwayREACTOME_REGULATION_OF_KIT_SIGNALING

SRC YES1 FYN SOS1

2.49e-05131994MM14565
PathwayREACTOME_REGULATION_OF_KIT_SIGNALING

SRC YES1 FYN SOS1

6.14e-05161994M537
PathwayREACTOME_SIGNALING_BY_ERBB2

SRC PTK6 NRG2 YES1 FYN SOS1

6.95e-05501996M553
Pubmed

The protein tyrosine kinase family of the human genome.

SRC ITK PTK6 JAK1 BTK FLT1 YES1 FRK FYN

8.56e-0983248911114734
Pubmed

Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade.

SRC ITK LCP2 FYN

1.25e-085248410636929
Pubmed

Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.

SRC FLT1 YES1 FYN

1.25e-085248412509223
Pubmed

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

HEXA BRPF3 SRC EPX PIK3C2B MYO18B DNM2 CACNA1F CSF2RA CELSR3 CELF2 LRP2 RIMS1 FYN SOS1

1.79e-083292481517474147
Pubmed

Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor.

SRC PTK6 YES1 FYN

3.74e-086248420606012
Pubmed

Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.

SRC NEB ITK BTK YES1 FYN

4.09e-0828248618067320
Pubmed

Global genetic analysis in mice unveils central role for cilia in congenital heart disease.

IFT140 PKD1L1 QSOX1 GLDC DNM2 DNAI1 LRP1 LRP2 DNAH11

4.46e-08100248925807483
Pubmed

Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development.

RELN SRC YES1 FYN

8.69e-087248412526739
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ZHX3 MYO7A KDM5C OBSCN ALDH1L1 NEB DYSF PIK3C2B PLK1 FLII FLT1 BRD3 ECPAS LCP2 DNAI1 VPS13D ATM

1.30e-074972481736774506
Pubmed

Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome.

MYO7A SRC ITK BTK YES1 FRK FYN

1.48e-0756248722745667
Pubmed

A directed protein interaction network for investigating intracellular signal transduction.

UBR1 EPRS1 IFT140 ACP5 SRC EXT2 PLD3 MAP3K12 MESD GLB1 SBF1 PRMT1 MBD4 PLK1 DNM2 EPS8L2 GEMIN2 RCN2 BRD3 KIAA1191 LCP2 ANKZF1 CRABP1 SNW1 PDE4DIP FYN

1.63e-0711242482621900206
Pubmed

Phospho-tyrosine dependent protein-protein interaction network.

ZHX3 IFT140 GALNT3 SRC MECOM BTK OSBPL6 EPS8L2 VPS39 UQCC2 LCP2 ANKZF1 YES1 USP2 FYN

3.11e-074102481525814554
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MYT1 SRC NAIP OBSCN ADGRV1 PLD3 MAP3K12 PTK6 SEL1L3 COL5A1 FUT10 NEDD4L TMPRSS6 WWP2 ECPAS BABAM2 CREBBP ANKH AR DPP9 SUGP2 NAT10 VPS41 LRP1 CSTF3 RIMS1 TANGO2 PATJ CTDSPL SLC4A5

3.35e-0714892483028611215
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

SRC ITK PTK6 MMP24 PRMT1 PLK1 MMP15 DNM2 FUT10 NSD1 ADAM30 BRD3 YES1 CREBBP FRK DPP9 LRP1 LRP2 FYN DNAH11

3.55e-077302482034857952
Pubmed

Localized activation of Src-family protein kinases in the mouse egg.

SRC YES1 FYN

3.58e-073248317449027
Pubmed

Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression.

HMOX1 CHRNA7 CHRFAM7A

3.58e-073248324350834
Pubmed

Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events.

SRC YES1 FYN

3.58e-073248316400523
Pubmed

Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases.

SRC YES1 FYN

3.58e-073248320176789
Pubmed

The proximal tubular α7 nicotinic acetylcholine receptor attenuates ischemic acute kidney injury through Akt/PKC signaling-mediated HO-1 induction.

HMOX1 CHRNA7 CHRFAM7A

3.58e-073248329674665
Pubmed

Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.

SRC YES1 FYN

3.58e-073248323497302
Pubmed

Requirement of SRC-family tyrosine kinases in fat accumulation.

SRC YES1 FYN

3.58e-073248316262245
Pubmed

Src family kinases are required for integrin but not PDGFR signal transduction.

SRC YES1 FYN

3.58e-073248310228160
Pubmed

Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.

SRC YES1 FYN

3.58e-07324837958873
Pubmed

Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake.

SRC YES1 FYN

3.58e-073248320080640
Pubmed

Mechanisms Regulating Acquisition of Platelet-Derived Factor V/Va by Megakaryocytes.

F5 LGALS8 LRP1

3.58e-073248325800007
Pubmed

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

SRC YES1 FYN

3.58e-073248310635317
Pubmed

EG-1 interacts with c-Src and activates its signaling pathway.

SRC BTK NEDD4L YES1 FYN

4.22e-0722248516964398
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

HEXA EPHX1 MAN2A2 GALNT3 EXT2 HMOX1 PLD3 OLFML2A CLPTM1L MESD FAT1 GLB1 SEL1L3 CYB5R3 PRMT1 POFUT2 IGSF3 COL5A1 B3GLCT NEDD4L ARV1 GNPTAB RCN2 CELSR3 LRP1 ATM

5.74e-0712012482635696571
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

ZHX3 MBTD1 MECOM ALDH1L1 AARS2 PLK1 GOT1 FLII IPO7 GEMIN2 BRD3 CREBBP PDE12 RPL4

1.23e-063982481435016035
Pubmed

Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor.

SRC YES1 FYN

1.43e-06424837681396
Pubmed

Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.

SRC YES1 FYN

1.43e-064248319258394
Pubmed

Sperm epidermal growth factor receptor (EGFR) mediates α7 acetylcholine receptor (AChR) activation to promote fertilization.

SRC CHRNA7 CHRFAM7A

1.43e-064248322577141
Pubmed

State and role of SRC family kinases in replication of herpes simplex virus 1.

SRC YES1 FYN

1.43e-064248316537602
Pubmed

Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases.

SRC YES1 FYN

1.43e-064248314559149
Pubmed

A unique role for Fyn in CNS myelination.

SRC YES1 FYN

1.43e-064248311245687
Pubmed

Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase.

SRC YES1 FYN

1.43e-06424837537495
Pubmed

FAK-dependent regulation of myofibroblast differentiation.

SRC YES1 FYN

1.43e-064248316585062
Pubmed

Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation.

SRC YES1 FYN

1.43e-064248325157176
Pubmed

Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells.

SRC YES1 FYN

1.43e-06424837521304
Pubmed

Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics.

SRC YES1 FYN

1.43e-064248325080486
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

EPRS1 SRC PLD3 F5 XAB2 AARS2 COX5A NOC4L PRMT1 FLII XRN2 IPO7 NEDD4L GEMIN2 LARS1 YES1 CIT SNW1 SUGP2 NAT10 CSTF3 EIF3B FYN

1.44e-0610242482324711643
Pubmed

Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.

SRC ITK BTK YES1 SNX18 FYN

1.51e-0650248619807924
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

IFT140 BRPF3 KDM5C ADGRV1 MESD SBF1 IGSF3 PDPR VPS39 LARS1 ECPAS ANKH CELSR3 DDHD1 CHD5 NAT10

1.54e-065292481614621295
Pubmed

Absence of Fyn and Src causes a reeler-like phenotype.

RELN SRC YES1 FYN

1.72e-0613248416162939
Pubmed

Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.

ACADM JAK1 AARS2 NOC4L MPST FLII XRN2 CIT PDE4DIP

1.98e-06156248929961565
Pubmed

The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome.

SRC YES1 FRK FYN

2.39e-0614248429568343
Pubmed

Identification of SH3 domain proteins interacting with the cytoplasmic tail of the a disintegrin and metalloprotease 10 (ADAM10).

SRC YES1 SNX18 FYN

3.24e-0615248425036101
Pubmed

Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases.

SRC YES1 FYN

3.54e-065248312846735
Pubmed

The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements.

SRC YES1 FYN

3.54e-065248317623777
Pubmed

Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac.

SRC YES1 FYN

3.54e-065248310844001
Pubmed

Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.

CHRNA7 CHRFAM7A FYN

3.54e-065248328822039
Pubmed

Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia.

SRC YES1 FYN

3.54e-065248318194650
Pubmed

TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.

SRC YES1 FYN

3.54e-065248318255094
Pubmed

Vav2 is required for cell spreading.

SRC YES1 FYN

3.54e-065248311448999
Pubmed

Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells.

SRC YES1 FYN

3.54e-065248322971575
Pubmed

Migration of sympathetic preganglionic neurons in the spinal cord is regulated by Reelin-dependent Dab1 tyrosine phosphorylation and CrkL.

RELN SRC FYN

3.54e-065248317394141
Pubmed

Palatal adhesion is dependent on Src family kinases and p38MAPK.

SRC YES1 FYN

3.54e-065248325354453
Pubmed

Isolation of novel heart-specific genes using the BodyMap database.

HHATL PDE4DIP PATJ

3.54e-065248311374908
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MON2 HEXA MAN2A2 MYO7A MYO10 OBSCN IPP DYSF FAT1 SBF1 PIK3C2B SPHK1 IGSF3 WDR24 FLII LPAR5 VPS39 NSD1 BABAM2 CIT CELSR3 SUGP2 CHD5

5.08e-0611052482335748872
Pubmed

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma.

MECOM POLQ CDH12 DNAH11

5.58e-0617248423502783
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MON2 IFT140 MBTD1 BRPF3 PSD KDM5C MECOM JAK1 ZNF610 FAT1 HMCN2 IQCM RCN2 ECT2L BRD3 CREBBP SUGP2 CHD5 NAT10 LRP1 LRP2 MAP2K7 SOS1

5.97e-0611162482331753913
Pubmed

Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells.

SRC JAK1 SPHK1 BTK AR ATM

5.98e-0663248630762338
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

HEXA ACP5 SLFN5 HMOX1 CHIT1 PLD3 NEB ANGPTL8 SPG21 FAT1 SRPX2 SPHK1 MBD4 NEDD4L MRGPRF GNPTAB RCN2 ALS2 NARS2 LGALS8 CELF2 PDE4DIP ZNF747 TANGO2 POLQ

6.97e-0612932482515342556
Pubmed

Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.

SRC YES1 FYN

7.05e-066248310861086
Pubmed

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

HEXA GLB1 CD1D

7.05e-066248316982810
Pubmed

Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors.

SRC YES1 FYN

7.05e-066248312923167
Pubmed

The small GTPase Arl8b regulates assembly of the mammalian HOPS complex on lysosomes.

VPS39 SNW1 VPS41

7.05e-066248325908847
Pubmed

ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCzeta-controlled ERK1/2 activity within the nucleus.

SRC YES1 FYN

7.05e-066248316723512
Pubmed

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

SRC YES1 FYN

7.05e-06624839799234
Pubmed

Protein tyrosine phosphatase-alpha complexes with the IGF-I receptor and undergoes IGF-I-stimulated tyrosine phosphorylation that mediates cell migration.

SRC YES1 FYN

7.05e-066248319420001
Pubmed

Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.

SRC YES1 FYN

7.05e-06624832404338
Pubmed

Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells.

SRC YES1 FYN

7.05e-06624831381360
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

HEXA EXT2 PLD3 XAB2 JAK1 CLPTM1L MESD FAT1 GLB1 NOC4L POFUT2 DNM2 MPST COL5A1 EPS8L2 IPO7 NEDD4L GEMIN2 LARS1 RCN2 ANKZF1 YES1 BABAM2 FYN RPL4

7.35e-0612972482533545068
Pubmed

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

MON2 HEXA ALDH1L1 PLD3 EPX DYSF QSOX1 GLB1 GGTLC3 CLN5 C8A GOT1 DNM2 MPST EPS8L2 NEDD4L WWP2 APOD FRK SNX18 LRP2 PATJ

9.94e-0610702482223533145
Pubmed

A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.

MON2 EPRS1 ALDH1L1 PHKA1 CLPTM1L GLB1 AARS2 GLDC PARL CYB5R3 PRMT1 POFUT2 MPST NARS2 PDE12 LRP1 MAP2K7

1.02e-056862481728380382
Pubmed

Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.

SRC YES1 FYN

1.23e-05724839632142
Pubmed

Tyrosine residues in phospholipase Cgamma 2 essential for the enzyme function in B-cell signaling.

SRC BTK FYN

1.23e-057248311606584
Pubmed

Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases.

SRC YES1 FYN

1.23e-057248310858437
Pubmed

Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress.

SRC YES1 FYN

1.23e-057248312538589
Pubmed

CMS: an adapter molecule involved in cytoskeletal rearrangements.

SRC YES1 FYN

1.23e-057248310339567
Pubmed

The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation.

SRC YES1 FYN

1.23e-057248310829062
Pubmed

NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice.

RELN SRC FYN

1.23e-057248316438943
Pubmed

Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin.

SRC YES1 FYN

1.23e-057248312558988
Pubmed

Interaction of SLP adaptors with the SH2 domain of Tec family kinases.

ITK BTK LCP2

1.23e-057248310556826
Pubmed

QM, a putative tumor suppressor, regulates proto-oncogene c-yes.

SRC YES1 FYN

1.23e-057248312138090
Pubmed

Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.

SRC ITK PTK6 BTK YES1 AR

1.41e-0573248624728074
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

SRC ALDH1L1 ADGRV1 PLD3 NEB DYSF EHD2 MMP24 FAT1 GLB1 GOT1 DNM2 MPST EPS8L2 APOD FRK VPS13D SNX18 LRP2 PATJ CTDSPL

1.47e-0510162482119056867
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

ZHX3 GALNT3 MYO7A NEB CLPTM1L COX5A IGSF3 DNM2 IPO7 SMARCAL1 ADAM30 BABAM2 CREBBP NARS2 DDHD1 DNAH11

1.62e-056382481631182584
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

EPRS1 ACADM AARS2 NOC4L DNM2 XRN2 IPO7 LARS1 RCN2 ECPAS SUGP2 NAT10 CSTF3 EIF3B MAP2K7 RPL4

1.62e-056382481633239621
Pubmed

Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays.

CLIC2 BTK ROBO3 PLK1 FLT1 NEDD4L TAF1B YES1 FYN

1.67e-05203248919953087
Pubmed

Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors.

SRC ITK PTK6 BTK LCP2 YES1

1.92e-0577248622973453
Pubmed

Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.

SRC YES1 FYN

1.95e-058248315190072
Pubmed

Redox-induced Src kinase and caveolin-1 signaling in TGF-β1-initiated SMAD2/3 activation and PAI-1 expression.

SRC YES1 FYN

1.95e-058248321829547
Pubmed

The GTPase dynamin binds to and is activated by a subset of SH3 domains.

SRC FYN SOS1

1.95e-05824838402898
Pubmed

Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase.

SRC YES1 CSF2RA

1.95e-05824837499252
Pubmed

Reelin activates SRC family tyrosine kinases in neurons.

RELN SRC FYN

1.95e-058248312526740
Pubmed

Receptor association and tyrosine phosphorylation of S6 kinases.

SRC BTK FYN

1.95e-058248316640565
Pubmed

p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

SRC YES1 FYN

1.95e-058248312640114
Pubmed

Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.

SRC YES1 FYN

1.95e-058248316921024
Pubmed

Identification of Itk/Tsk Src homology 3 domain ligands.

SRC ITK FYN

1.95e-05824838810341
Cytoband2q24-q31

GALNT3 LRP2

8.69e-05324822q24-q31
GeneFamilySH2 domain containing

SRC ITK PTK6 BTK LCP2 YES1 FRK FYN

7.28e-061011798741
CoexpressionGSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP

MAGEA4 IFT140 BCAT2 EXT2 OLFML2A MMP24 GLDC PLK1 IGSF3 FLII CD1D CTDSPL

4.60e-0720024612M9594
CoexpressionGSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN

MORC1 MAN2A2 MYO10 ACP5 ACSS2 PLD3 NEB ANGPTL8 MGAT3 NEDD4L TIMP4

3.25e-0620024611M5693
CoexpressionLUI_THYROID_CANCER_CLUSTER_5

EPHX1 ACADM HLA-DRB1 CHRNA7

1.26e-05162464M13462
CoexpressionSMID_BREAST_CANCER_NORMAL_LIKE_UP

HGF RELN HLA-DRB1 ITK MGAT3 CLIC2 VNN2 BTK SEL1L3 ROBO3 MRC1 LCP2 CD1D CSF2RA CELF2 FYN

1.57e-0548524616M8513
CoexpressionGSE17721_CTRL_VS_CPG_24H_BMDC_UP

HEXA F5 APOM JAK1 CLPTM1L CASQ2 ANKZF1 CIT CRYGB CELF2

2.09e-0520024610M3771
ToppCell10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MYO7A ACP5 HMOX1 PLD3 EHD2 SPHK1 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.33e-0919924712cbd423c31d75f6d2f5ae85d2241641fcbe630b81
ToppCell10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

MYO7A ACP5 HMOX1 PLD3 EHD2 SPHK1 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.33e-0919924712980b10b81ee9dc952e3be25bd294201ce5a4ca8b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FAT1 TRIM16L ROBO3 B3GLCT ARV1 CASQ2 CIT CELSR3 SPDYA POLQ

2.90e-08164247104ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SRC SLFN5 HMOX1 PLD3 DYSF MMP24 MRC1 PDE4DIP LRP1

5.97e-081772471026bad614560609d318bfc9c235a698bca4e1c22c
ToppCellfacs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPTL8 F5 GLDC C8A ABCC2 MMP15 MPST EPS8L2 TMPRSS6 UGT1A1

7.76e-081822471077ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCellfacs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPTL8 F5 GLDC C8A ABCC2 MMP15 MPST EPS8L2 TMPRSS6 UGT1A1

7.76e-08182247104921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCellfacs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPTL8 F5 GLDC C8A ABCC2 MMP15 MPST EPS8L2 TMPRSS6 UGT1A1

7.76e-0818224710770ce9f3f4538d0181a0181543841bc964c68274
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN OBSCN ADGRV1 NEB FAT1 CACNA1F ANO2 LRP2 UNC13C DNAH11

8.59e-08184247102cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN OBSCN ADGRV1 NEB FAT1 CACNA1F ANO2 LRP2 UNC13C DNAH11

8.59e-08184247102b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RELN OBSCN ADGRV1 NEB FAT1 CACNA1F ANO2 LRP2 UNC13C DNAH11

8.59e-0818424710ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellFrontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

MORC1 RELN IL20RA NEB CHRNA7 LACTBL1 ABCC2 TPH2

1.21e-071042478b5ca6e589f414e549f4990fe334d4ee54829b298
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ACP5 SRC PLD3 F5 COX5A SPHK1 GNPTAB ANKH PDE4DIP RUFY4

1.48e-07195247101f07502597e9476345b07f9f25aeeb6c1de13013
ToppCellfacs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANGPTL8 F5 GLDC C8A ABCC2 MMP15 MPST TMPRSS6 UGT1A1

8.88e-071832479d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCellBAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-071852479ae966929fb5bbb08ffcbac76cb21941638727f55
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-0718524793beebaa92275086b1fae5f8c0c3d54016c5ba2aa
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-07185247942939b294ea3e871274d8b73124c850dc1904fd2
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-0718524797a3612520ae4f0cd61480eadba31eecce001419d
ToppCellBAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-071852479ceff11cfa679147ccfd0a0f8079e697a6bea34d9
ToppCellBAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-0718524799aea5ed8f9cee5ee933891203aac7adb85d68201
ToppCellSevere_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

HEXA EPHX1 ACP5 CHIT1 PLD3 CLIC2 TBC1D12 ROBO3 MRC1

9.72e-071852479f7ef0d7740b4cfedc38846e802898c402dc411fd
ToppCell10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ACP5 SRC EHD2 SPHK1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.02e-061862479c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68
ToppCellPCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 PHKA1 GLDC SEL1L3 EPS8L2 ESYT3 LRP2 PATJ

1.06e-061872479db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ACP5 F5 EHD2 SPHK1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.11e-061882479762b52f21d2bc5409f86746a904c4358490be9c0
ToppCellfacs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 DYSF EHD2 PIK3C2B MMP15 NOS2 FLT1 TIMP4

1.21e-06190247989d1d686cc683206534e2157554d7d0df5d53497
ToppCellfacs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 DYSF EHD2 PIK3C2B MMP15 NOS2 FLT1 TIMP4

1.21e-06190247965ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640
ToppCell356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

HGF MYO7A HLA-DRB1 NAIP HMOX1 PLD3 MRC1 LPAR5 ANKH

1.21e-061902479d541e076137cf7334bdb0ed69db2f9a27c668c65
ToppCell10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ACP5 SRC EHD2 SPHK1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.27e-0619124794cebaf31d4f09f4ab273a819ad5cbff7d9a9b341
ToppCell10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ACP5 SRC EHD2 SPHK1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.27e-061912479be2fe2583bdcee0b35c43a347da9c4adb93e30e0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ITK BTK OSBPL6 MRC1 CPA3 LCP2 CSF2RA CELF2 FYN

1.27e-061912479468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPHX1 RELN DYSF EHD2 CLIC2 SPHK1 CYB5R3 MRC1 APOD

1.32e-061922479ee9a23a4f00424a50bd7907cf3b12dc50027877e
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPHX1 RELN DYSF EHD2 CLIC2 SPHK1 CYB5R3 MRC1 APOD

1.50e-06195247936d4a11bc77a4cc97a22525c78ef8359f4a3ca66
ToppCell(1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis

ACP5 PTGIS HOXC10 CYB5R3 COL5A1 MRGPRF CRABP1 ANKH LRP1

1.50e-06195247978978d85273e5463a7f43e4c121e647fa6aba42b
ToppCell10x3'2.3-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ACP5 HMOX1 PLD3 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.57e-061962479bd2c2de103e28b65ea537c22f71225cb0deef1e0
ToppCell10x3'2.3-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ACP5 HMOX1 PLD3 MRC1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

1.57e-061962479072a4150ae521c6589b0f7cd60e975fb33715bf4
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HEXA HLA-DRB1 ACP5 HMOX1 PPP1R15A CHRFAM7A MRC1 CSF2RA LRP1

1.57e-0619624795fe6534af65d43eeacd4b031310242b4f706008b
ToppCellParenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CPPED1 HLA-DRB1 ACP5 MGAT3 BTK MRC1 LCP2 CSF2RA LRP1

1.78e-0619924797ee2805fd9143eba11bf6832267b62189683608b
ToppCellSevere_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30)

HEXA HLA-DRB1 ACP5 HMOX1 CHIT1 PLD3 MRC1 UQCC2 LRP1

1.85e-06200247930448a41ca64d6f0fedaff0b7a6670dd33cdf2c5
ToppCellBAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HEXA HLA-DRB1 ACP5 HMOX1 CHIT1 PLD3 MRC1 UQCC2 LRP1

1.85e-0620024794f481d87e30195365900acb5d50641a9e7b2f462
ToppCellBAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HEXA HLA-DRB1 ACP5 HMOX1 CHIT1 PLD3 MRC1 UQCC2 LRP1

1.85e-062002479cf720d3973e79ffd4c6e763a7284799ced22a274
ToppCellBAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HEXA HLA-DRB1 ACP5 HMOX1 CHIT1 PLD3 MRC1 UQCC2 LRP1

1.85e-0620024795490393c5f54748f912676e19b58bd1320415a06
ToppCellBAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

HEXA HLA-DRB1 ACP5 HMOX1 CHIT1 PLD3 MRC1 UQCC2 LRP1

1.85e-062002479df821ac12953e44fcfedbbefb35a4976e406ccd6
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

POFUT2 COL5A1 EPS8L2 NRG2 AR ESYT3 TIMP4 FYN

3.20e-0616024788aaf6ac4f33ea291387fdbf9ff1a91d559391774
ToppCellPND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEXA F5 SPG21 PHKA1 FUT10 CSF2RA AP5B1 POLQ

5.02e-0617024787534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell3'_v3-blood-Mast-Mast_cell_granulo-myelo|blood / Manually curated celltypes from each tissue

EPHX1 MECOM CHIT1 ACSS2 EPX CPA3 APOC4 UNC13C

6.48e-061762478d421b6b8e13894dbcf29548c0a6516c3dee8f9b1
ToppCellfacs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGF ACSS2 PLD3 ANGPTL8 ITK POLN CPA3 FYN

7.04e-06178247841745a589567ca5ea6d06331f4c8da03595b5f5c
ToppCellfacs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGF ACSS2 PLD3 ANGPTL8 ITK POLN CPA3 FYN

7.04e-061782478eb940dd64c973f68bcaad6069d3bd56383329db5
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HEXA HLA-DRB1 ACP5 PLD3 QSOX1 GLB1 MRC1 LRP1

7.04e-0617824780b398656f26c4061b11ccf98908d0e2e1367585a
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GABRD PSD RGS9 CACNA1B ANO2 TMPRSS6 CIT CHD5

7.33e-061792478a3922476f33d2e4137a12dbda21a1703dff79684
ToppCellLA-10._Endothelium_II|World / Chamber and Cluster_Paper

MECOM PTGIS NALF1 HMCN2 SPHK1 ANO2 FLT1

7.42e-061282477071becbe97598c2b65580b0989eb664d6fd6c85a
ToppCellCOVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

ALDH1L1 FAT1 GLDC KCTD16 ABCC2 SLC13A1 LRP2 PATJ

7.64e-061802478358923e4228035a3e90e2957392089219e90dcd7
ToppCellHSPCs-Erythroblasts|HSPCs / Lineage and Cell class

IFT140 ACP5 SPHK1 PLK1 PMM1 COL5A1 TMPRSS6 TANGO2

7.95e-0618124784ded490f190af7ace343acdf317edc7373484d08
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MECOM ADGRV1 FAT1 NALF1 EPS8L2 NEDD4L CIT UNC13C

8.97e-061842478102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCelldroplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GALNT3 MYO7A PLD3 MRC1 DDHD1 CHD5 LRP1 PATJ

8.97e-061842478bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCelldroplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GALNT3 MYO7A PLD3 MRC1 DDHD1 CHD5 LRP1 PATJ

8.97e-06184247815ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell10x3'2.3-week_14-16-Myeloid_macrophage-stroma-osteoclast|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ACP5 EHD2 SPHK1 GNPTAB ANKH ESYT3 PDE4DIP RUFY4

9.33e-0618524785ed49b6d8214c6119355a6d3ee4e25d40bcc0c53
ToppCelldroplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 MYO7A PLD3 MRC1 FRK DDHD1 CHD5 PATJ

9.70e-0618624788f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEXA MYO7A HMOX1 PLD3 MRC1 LCP2 DDHD1 LRP1

9.70e-0618624787950e03ea080238c168b9d807e217f459acdfb28
ToppCelldroplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GALNT3 MYO7A PLD3 MRC1 FRK DDHD1 CHD5 PATJ

9.70e-061862478f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCellMonocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis

EPHX1 MYO7A PLD3 NEB TBC1D12 MRC1 FRK CTDSPL

1.01e-05187247859e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HLA-DRB1 ACP5 CLIC2 MRC1 ECPAS PDE4DIP LRP1 FYN

1.05e-051882478e35104ca327c2d9eb6ffed658051f62f855a0a0e
ToppCelldroplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GALNT3 MYO7A PLD3 MRC1 DDHD1 CHD5 PATJ DNAH11

1.09e-05189247898f517af255ef234eefc3ed7e6c1d63331ab8af0
ToppCellAdult|World / Lineage, Cell type, age group and donor

HMOX1 ACSS2 DNM2 MRC1 LCP2 DPP9 PDE4DIP LRP2

1.09e-0518924785cd285bfad973125d46d704fec18b21266a63379
ToppCellfacs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 EHD2 PIK3C2B MMP15 FLT1 EPS8L2 TIMP4

1.09e-051892478d424d2554595b2304219f7324406b401711af7c2
ToppCelldroplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GALNT3 MYO7A PLD3 MRC1 DDHD1 CHD5 PATJ DNAH11

1.09e-051892478f7e9b6e6a4de297b660a5b6c9a62f860c147185e
ToppCellfacs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 EHD2 PIK3C2B MMP15 FLT1 EPS8L2 TIMP4

1.09e-051892478393ec5954a12d6cf67bb435dcc34ff0b14c81e9f
ToppCellfacs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 EHD2 PIK3C2B MMP15 FLT1 EPS8L2 TIMP4

1.09e-051892478bec57459ad4bab15b2532b57722549fec2e771fb
ToppCellCOVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type

FAT1 KCTD16 SEL1L3 ABCC2 AR SLC13A1 LRP2 PATJ

1.09e-0518924780be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 GLDC SEL1L3 EPS8L2 AR LRP2 PATJ

1.13e-051902478625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HLA-DRB1 ACP5 CLIC2 MRC1 ECPAS PDE4DIP LRP1 FYN

1.18e-0519124785c0c44612b4cdbf89c0f1f219416374a7541f610
ToppCellfacs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 DYSF EHD2 MMP15 NOS2 FLT1 TIMP4

1.18e-051912478a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

MON2 UBR1 ITK GNPTAB NSD1 CELF2 DDHD1 POLQ

1.18e-0519124789454f642c3621370fa23640b631301346b300950
ToppCellfacs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO10 SLFN5 DYSF EHD2 MMP15 NOS2 FLT1 TIMP4

1.18e-051912478827be47d3574c6c5b021c6f1c1670834344f10cb
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 GLDC SEL1L3 EPS8L2 AR LRP2 PATJ

1.22e-051922478d3634574b2e8d2ded6446969361b70761b331aea
ToppCellPCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 GLDC SEL1L3 PLK1 CIT AR LRP2

1.22e-05192247825378b5e4b0cea8415ff125783511fc25a56fc00
ToppCellPCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 GLDC SEL1L3 EPS8L2 AR LRP2 PATJ

1.22e-051922478b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor

MYO7A NAIP HMOX1 MRC1 LCP2 ANKH CSF2RA LRP1

1.27e-05193247831c0978ba78c9516d498aec0798902e57555e557
ToppCellmyeloid-macrophage|World / Lineage and Cell class

EPHX1 MYO7A ACP5 HMOX1 PLD3 SRPX2 MRC1 USP2

1.27e-051932478b13e694123b87ed8ad1786feb996398ddd84e94b
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ITK SEL1L3 MRC1 LCP2 CSF2RA CELF2 ATM FYN

1.32e-0519424784dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCellPCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

GALNT3 ADGRV1 GLDC SEL1L3 EPS8L2 AR LRP2 PATJ

1.32e-051942478f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCellPCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

MORC1 HLA-DRB1 HMOX1 CLIC2 MRC1 LPAR5 LCP2 CSF2RA

1.37e-051952478e8fb552f9ab77b656c27abc66af523b56cd9f9ad
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HLA-DRB1 HMOX1 MRC1 LCP2 ANKH CSF2RA CELF2 LRP1

1.37e-051952478247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

HEXA EPHX1 HLA-DRB1 ACP5 HMOX1 PLD3 MRC1 LRP1

1.37e-051952478ba494be431916d43c1d480f65bed674c0722c710
ToppCellMesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class

DYSF F5 PTGIS GLDC EPS8L2 WWP2 ANKH CLEC3A

1.37e-051952478b95a631d54c6cf85e48e1e638703206aaaebc073
ToppCell(3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

HGF MYO7A HLA-DRB1 NAIP HMOX1 PLD3 MRC1 LPAR5

1.37e-051952478e4b5e4b8832669fb4d1661ecd828b81e621d35c4
ToppCell356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells)

MYO7A HLA-DRB1 ACP5 NAIP HMOX1 PLD3 MRC1 ANKH

1.37e-0519524789231e929657542b78a6480d44402866511129c7f
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

F5 PTGIS FAT1 HMCN2 KCTD16 IGSF3 COL5A1 CELF2

1.42e-05196247824d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ACP5 HMOX1 PLD3 MRC1 ANKH ESYT3 PDE4DIP RUFY4

1.42e-051962478e0447ad2efb021b63c7fef000d39b6b21fbe6113
ToppCellfacs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HMOX1 PPP1R15A SPHK1 COL5A1 TMPRSS6 APOD USP2 LRP1

1.42e-0519624788209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCellfacs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMOX1 PPP1R15A SPHK1 COL5A1 TMPRSS6 APOD USP2 LRP1

1.42e-05196247834020d6553309daa269dff05de0a8567211ea4d2
ToppCell10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

ACP5 HMOX1 PLD3 MRC1 ANKH ESYT3 PDE4DIP RUFY4

1.42e-0519624783bca88eede3dd7368715ced02e3bacd1e3e82cab
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-DRB1 HMOX1 CLIC2 BTK MRC1 LCP2 CD1D CSF2RA

1.42e-051962478fa24d7c4b7c65e98b209db302a16c58ceac1a105
ToppCell10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CPPED1 SLFN5 PPP1R15A PLD3 EPX BTK CPA3 ALS2

1.47e-05197247861f909737c5f630beffdd326c6844215643dbdde
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HGF HLA-DRB1 ACP5 NAIP HMOX1 CHIT1 MRC1 LRP1

1.47e-0519724782efb5acd56b96e5afd8d72b927f1d53cc443766f
ToppCell10x3'2.3-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ACP5 EHD2 COX5A SPHK1 GNPTAB ANKH PDE4DIP RUFY4

1.47e-0519724781bf69db7e830315c8fa85e6e85b0cb94014e9169
ToppCelldistal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MYO7A HLA-DRB1 NAIP HMOX1 MRC1 LPAR5 ANKH CSF2RA

1.47e-051972478e77c91f5a1f5a292eda41abf3b1e31180f2c61e1
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-DRB1 NAIP HMOX1 BTK MRC1 LCP2 CD1D CSF2RA

1.53e-05198247879c8ab15e73f727c5e110ab9eab3ccb5edf9f714
ToppCellParenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

ACP5 PLD3 F5 LPAR5 GNPTAB ANKH PDE4DIP RUFY4

1.53e-051982478a7eed9eeb728a8796e2780090cc244856efd8c65
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NALF1 OSBPL6 CACNA1B PAK5 CELF2 CHD5 RIMS1 CDH12

1.53e-0519824788ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-DRB1 NAIP HMOX1 CLIC2 MRC1 LCP2 CD1D CSF2RA

1.53e-05198247888635244a0b306d2cc50b8412fe47bb359c9cf00
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

NALF1 KCTD16 OSBPL6 CACNA1B PAK5 CELF2 CHD5 RIMS1

1.53e-0519824784ca5ff320905ab4ff60ed90a5522227c782142a6
DrugH088

IL20RA F5 APOM ABCC2 FLII APOC4 APOD AR

1.45e-06752458CID000004542
DrugNizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A

PPP1R15A NEB MAP3K12 MGAT3 HOXC10 SBF1 CLIC2 MMP15 DNM2 COL5A1 ECPAS LRP2

1.61e-06197245125406_DN
DrugSulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A

IL20RA PPP1R15A PLD3 XAB2 EHD2 HOXC10 NALF1 VNN2 C8A MMP15 EPM2A CREBBP

1.70e-06198245126799_UP
Drughomocysteine

ALDH1L1 HMOX1 F5 CHRNA7 APOM CHRFAM7A NOS2 PDPR APOC4 APOD KYAT1 TIMP4 TPH2

6.78e-0626624513CID000000778
DrugBeta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A

HGF RGS9 HMOX1 PPP1R15A PTGIS CLIC2 TMPRSS6 GNPTAB RDH16 SLC13A1 PDE4DIP

7.92e-06192245113807_UP
Drugponatinib

SRC PTK6 JAK1 FLT1 YES1 FRK FYN

8.50e-06682457ctd:C545373
DrugKarakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A

IFT140 MYT1 HMOX1 XAB2 NALF1 CLIC2 ROBO3 MMP15 CATSPER2 ZNF747 ATM

8.73e-06194245114763_DN
DrugCitalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A

SRC ITK OLFML2A ROBO3 DNM2 EPM2A ANKH AR LRP1 ZNF747 ATM

1.01e-05197245113820_DN
DrugOleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A

MBTD1 MYO10 HMOX1 HOXC10 RHBDD3 COL5A1 SUGP2 PDE4DIP LRP2 ZNF747 ATM

1.01e-05197245111518_DN
DrugNadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A

ZHX3 IFT140 ALDH1L1 DYSF OLFML2A SBF1 COL5A1 EPM2A GNPTAB PDE4DIP ZNF747

1.01e-05197245116091_DN
DrugMIBK

PTK6 GLB1 PRMT1 DNM2 CACNA1B CSF2RA CTDSPL

1.03e-05702457CID000007909
Drug6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A

ZHX3 SRC PPP1R15A MAP3K12 POFUT2 EPM2A GNPTAB APOD SUGP2 PDE4DIP ZNF747

1.06e-05198245116073_DN
DrugCefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A

KDM5C SRC HMOX1 XAB2 OLFML2A SBF1 RHBDD3 MMP15 EPM2A ATM CTDSPL

1.06e-05198245113259_DN
DrugTiapride hydrochloride [51012-33-0]; Down 200; 11uM; HL60; HT_HG-U133A

EPHX1 KDM5C PPP1R15A SBF1 VNN2 CLN5 RHBDD3 POFUT2 FLII CATSPER2 ZNF747

1.11e-05199245112331_DN
Drughaloperidol; Up 200; 10uM; PC3; HT_HG-U133A

HGF ZHX3 HMOX1 F5 RHBDD3 CWH43 NRG2 BABAM2 LGALS8 PDE4DIP ATM

1.11e-05199245114427_UP
DrugTHIP Hydrochloride; Up 200; 22.6uM; MCF7; HT_HG-U133A

MYO7A KDM5C SRC ALDH1L1 PTGIS ITK EHD2 CLIC2 ANKZF1 CRABP1 PATJ

1.11e-05199245116511_UP
Druggabapentin

HMOX1 NOS2 GOT1 CACNA1B KYAT1 PATJ

4.08e-05592456ctd:C040029
Drug2-methylaspartate

NOS2 GOT1 CIT

4.17e-0572453CID000002109
Drug5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA

CPPED1 SRC HMOX1 MAP3K12 PTK6 HOXC10 SBF1 COL5A1 CATSPER2 PDE4DIP

4.84e-0519324510950_UP
DrugHarmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A

MORC1 MON2 KDM5C PLD3 PTGIS ANO2 KDM4D PDE12 PDE4DIP CSTF3

5.06e-05194245105855_UP
DrugFurazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A

GABRD ZHX3 ALDH1L1 NEB EPX SBF1 MMP15 AR CATSPER2 ATM

5.06e-05194245104178_DN
DrugSisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A

SRC HMOX1 PPP1R15A PLD3 EPX DYSF MAP3K12 RHBDD3 APOD CTDSPL

5.06e-05194245104132_DN
DrugMethoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A

HMOX1 EHD2 SBF1 PIK3C2B VPS39 VPS13D ELMO3 PDE12 CATSPER2 ATM

5.28e-05195245105455_DN
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; PC3; HT_HG-U133A

CPPED1 ITK TBC1D12 RHBDD3 COL5A1 ANKZF1 VPS13D CELSR3 CELF2 FYN

5.28e-05195245107140_UP
Drugfluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A

MORC1 MYT1 ALDH1L1 PTGIS CASQ2 APOC4 TEX13A LCP2 PDE4DIP MAP2K7

5.51e-05196245104461_UP
DrugS(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MBTD1 CPPED1 NEB HOXC10 SBF1 CLIC2 COL5A1 EPM2A FRK LRP2

5.75e-05197245105400_DN
DrugAC1L1J0H

SRC HMOX1 ITK JAK1 PIK3C2B BTK NOS2 LCP2 YES1 FYN

5.75e-0519724510CID000004813
DrugDiloxanide furoate [3736-81-0]; Up 200; 12.2uM; HL60; HT_HG-U133A

MYT1 MAP3K12 MMP24 COL5A1 CWH43 NRG2 USP2 CHD5 PDE4DIP MAP2K7

5.75e-05197245103062_UP
DrugEnoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A

IFT140 KDM5C XAB2 OLFML2A PIK3C2B RHBDD3 APOD ANKZF1 ELMO3 PDE4DIP

5.75e-05197245105616_DN
DrugSulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A

HMOX1 NEB OLFML2A CLN5 EPM2A WWP2 TIMP4 PDE4DIP TUBD1 SOS1

5.75e-05197245105843_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

CPPED1 MAP3K12 CLN5 ANKZF1 KYAT1 VPS13D ELMO3 SUGP2 FYN SOS1

5.75e-05197245106222_DN
DrugProxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A

IFT140 SRC PLD3 MAP3K12 COL5A1 FRK PDE12 ZNF747 PATJ CTDSPL

5.75e-05197245105993_DN
DrugEthisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

MON2 IFT140 GALNT3 ALDH1L1 PPP1R15A NEB PTK6 SBF1 ABCC2 ROBO3

5.75e-05197245102326_DN
Drug15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A_EA

HMOX1 PPP1R15A SEL1L3 RHBDD3 POFUT2 AR LGALS8 PDE4DIP FYN

5.85e-0515924591011_UP
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

ZHX3 IFT140 KDM5C HMOX1 MMP15 PMM1 EPM2A PDE4DIP PATJ SOS1

6.00e-05198245103175_DN
DrugCephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A

HMOX1 OLFML2A SBF1 CRABP1 KYAT1 VPS13D ELMO3 PDE12 ZNF747 ATM

6.00e-05198245106790_DN
DrugTropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A

HOXC10 NALF1 SBF1 RHBDD3 IGSF3 CWH43 GNPTAB BABAM2 VPS13D VPS41

6.00e-05198245105790_DN
DrugNitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A

OLFML2A HOXC10 SBF1 CLIC2 VPS39 APOD VPS13D PDE12 LRP2 ZNF747

6.00e-05198245105405_DN
DrugClenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A

DYSF PTGIS MMP15 EPM2A GNPTAB CRABP1 ELMO3 CELF2 ZNF747 CTDSPL

6.00e-05198245105266_DN
DrugQuinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A

HMOX1 NEB F5 MAP3K12 HOXC10 CLN5 COL5A1 CRABP1 VPS13D SUGP2

6.00e-05198245106267_UP
DrugRoxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

KDM5C HMOX1 PTK6 PIK3C2B SPHK1 RHBDD3 FLII CELSR3 PDE4DIP LRP2

6.00e-05198245105470_DN
DrugDichlorvos

GABRD HMOX1 XAB2 NOS2 GOT1 AR ATM

6.17e-05922457ctd:D004006
Drugclozapine; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ZHX3 IFT140 MAN2A2 PPP1R15A PTK6 HOXC10 APOD AR PDE12 PDE4DIP

6.26e-05199245101009_UP
DrugCholecalciferol [67-97-0]; Down 200; 10.4uM; MCF7; HT_HG-U133A

XAB2 HOXC10 NALF1 RHBDD3 MMP15 EPM2A BRD3 BABAM2 KYAT1 PDE4DIP

6.26e-05199245105002_DN
DrugMethapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A

HGF MYO7A MYT1 ALDH1L1 NEB OLFML2A NRG2 ECPAS PDE12 MAP2K7

6.26e-05199245104990_UP
DrugGalanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A

GABRD IFT140 NEB OLFML2A SRPX2 VNN2 NRG2 CHD5 PDE4DIP MAP2K7

6.26e-05199245102787_UP
Drug(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A

ZHX3 MBTD1 IPP MAP3K12 XAB2 PTK6 HOXC10 AR CENPI ATM

6.26e-05199245103531_DN
DrugTropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A

RELN IL20RA PLD3 DYSF MGAT3 RHBDD3 POFUT2 CRABP1 LGALS8 SOS1

6.26e-05199245103569_UP
Drugcypermethrin

EPHX1 HMOX1 NEB KCNJ9 MBD4 NOS2 GOT1 ALS2 AR KYAT1 ATM CDH12

6.36e-0528424512ctd:C017160
DrugIsoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A

KDM5C HMOX1 PLD3 DYSF SBF1 COL5A1 ANKZF1 KYAT1 CELSR3 ZNF747

6.53e-05200245104789_DN
DrugPyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A

RELN MAN2A2 MYO7A ALDH1L1 EPX MMP24 MMP15 ECPAS VPS13D CTDSPL

6.53e-05200245101474_UP
DrugFlunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A

MORC1 HGF VNN2 CREBBP VPS13D SLC13A1 PDE4DIP ZNF747 RIMS1 FYN

6.53e-05200245106023_UP
Druglatanoprost acid

PTGIS MMP24 MMP15 NOS2 TIMP4

6.70e-05402455CID006441636
DrugEthoxyquin

EPHX1 HMOX1 ABCC2 AR UGT1A1

6.70e-05402455ctd:D005015
DrugAC1L1FO2

HMOX1 KDM5D JAK1 NOS2

6.78e-05212454CID000003321
DrugUDP-N-acetylglucosamine

HEXA GALNT3 EXT2 CHIT1 MGAT3 GLB1 B3GLCT GNPTAB UGT1A1 SLC4A5

7.39e-0520324510CID000001167
DrugBiliton

MYO7A ACP5 DNAI1 SLC4A5 DNAH11

7.57e-05412455CID000002974
Drug2,4,5,2',5'-pentachlorobiphenyl

MBTD1 PSD MYT1 RGS9 SMIM15 ISM2 ABCC2 PLK1 NOS2 CACNA1F FLT1 EPS8L2 NEDD4L ALS2 MAGEB16 APOD BABAM2 AR UGT1A1 ESYT3 CD1D ELMO3 CELSR3 TIMP4 PDE4DIP CENPI RIMS1 ATM POLQ SLC4A5 CDH8 RUFY4

8.05e-05144124532ctd:C009828
DrugN-methyl-DL-aspartic acid

GABRD RELN SRC ADGRV1 CHRNA7 FAT1 COX5A CHRFAM7A NOS2 CACNA1B FLII CACNA1F GNPTAB NRG2 APOD CIT LRP1 RIMS1 FYN

9.48e-0565524519CID000004376
Drugmagnesium

MYO7A ACP5 SRC RGS9 ADGRV1 EPX PHKA1 MMP24 GLB1 AARS2 COX5A SPHK1 KCNJ9 POLN PLK1 MMP15 NOS2 PMM1 PDPR CASQ2 YES1 NARS2 KYAT1 DNAI1 TUBD1 FYN CTDSPL RPL4 DNAH11 SOS1

9.73e-05132524530CID000000888
Drugvandetanib

SRC PTK6 FLT1 EPM2A YES1 FRK FYN

9.85e-05992457CID003081361
DrugK00271

MYT1 PLK1 NSD1

9.86e-0592453CID005486761
DrugEmodin

SRC HMOX1 JAK1 ABCC2 NOS2 RCN2 UGT1A1 CELSR3 ATM

1.12e-041732459ctd:D004642
DrugK 81

GLB1 CIT

1.15e-0422452CID005744870
DrugPyridoxamine-5'-Phosphate

BCAT2 KYAT1

1.15e-0422452DB02142
DrugNSC221991

HMOX1 F5 ABCC2 YES1 CIT KYAT1

1.26e-04722456CID000004580
DrugDasatinib

SRC YES1 FYN

1.40e-04102453DB01254
Diseasetransverse temporal cortex volume measurement

HGF CFAP95 UNC13C SOS1

8.77e-07102414EFO_0010336
Diseaseschizophrenia (implicated_via_orthology)

RELN MAN2A2 CHRNA7 CHRFAM7A ASTN1 RIMS1 MAP2K7

1.41e-06682417DOID:5419 (implicated_via_orthology)
Diseasecolorectal cancer (implicated_via_orthology)

SRC YES1 FRK SNX18 FYN

4.21e-06302415DOID:9256 (implicated_via_orthology)
Diseasebilirubin metabolic disorder (is_implicated_in)

HGF ABCC2 UGT1A1

1.06e-0562413DOID:2741 (is_implicated_in)
DiseaseAutistic Disorder

RELN KDM5C HLA-DRB1 CHRNA7 ROBO3 MBD4 NOS2 NSD1 AR TPH2 RIMS1

1.11e-0526124111C0004352
DiseaseSchizophrenia

GABRD PI4K2B RELN PSD HLA-DRB1 RGS9 HMOX1 CHRNA7 CHRFAM7A CACNA1B CACNA1F VPS39 APOD CSF2RA CELF2 TPH2 LRP1 LRP2 ATM FYN MAP2K7

1.34e-0588324121C0036341
Diseaselung non-small cell carcinoma (is_implicated_in)

CHRNA7 JAK1 CLPTM1L FAT1 ABCC2 UGT1A1 ATM MAP2K7

1.98e-051392418DOID:3908 (is_implicated_in)
Diseaseprostate carcinoma in situ (is_marker_for)

FLT1 TIMP4 ATM MAP2K7

7.62e-05282414DOID:8634 (is_marker_for)
Diseasemelanoma

ADGRV1 CLPTM1L MMP24 HMCN2 OSBPL6 ATM FYN

8.23e-051262417EFO_0000756
Diseasepulmonary emphysema (is_implicated_in)

EPHX1 HMOX1 CLPTM1L

8.46e-05112413DOID:9675 (is_implicated_in)
Diseaseintestinal cancer (implicated_via_orthology)

SRC YES1 FRK FYN

1.30e-04322414DOID:10155 (implicated_via_orthology)
Diseasestatus epilepticus (biomarker_via_orthology)

RELN HMOX1 ABCC2 XRN2 APOD ATM

1.75e-041002416DOID:1824 (biomarker_via_orthology)
Diseasebrain ischemia (implicated_via_orthology)

SRC HMOX1 PTGIS SOS1

1.86e-04352414DOID:2316 (implicated_via_orthology)
Diseaseendothelial growth factor measurement, hepatocyte growth factor measurement

HGF SOS1

1.98e-0432412EFO_0006900, EFO_0006903
Diseaseendometrial cancer (is_implicated_in)

JAK1 AR UGT1A1 ATM

2.08e-04362414DOID:1380 (is_implicated_in)
Diseasealcohol use disorder (implicated_via_orthology)

PSD KDM5C KDM5D ACSS2 CLIC2 EPS8L2 CREBBP UNC13C

2.13e-041952418DOID:1574 (implicated_via_orthology)
DiseasePre-Eclampsia

EPHX1 HMOX1 FLT1

2.79e-04162413C0032914
DiseaseBlood Coagulation Disorders

HMOX1 F5 COL5A1

2.79e-04162413C0005779
Diseasemultiple myeloma

HGF MECOM POLQ CDH12 DNAH11 SOS1

3.24e-041122416EFO_0001378
DiseaseLiddle syndrome (implicated_via_orthology)

NEDD4L WWP2

3.94e-0442412DOID:0050477 (implicated_via_orthology)
Diseasehepatitis (biomarker_via_orthology)

F5 NOS2

3.94e-0442412DOID:2237 (biomarker_via_orthology)
Diseasetartrate-resistant acid phosphatase type 5 measurement

ACP5 GNPTAB

3.94e-0442412EFO_0020763
Diseasesyndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)

KDM5C KDM5D

3.94e-0442412DOID:0060809 (implicated_via_orthology)
Diseasemelancholic depression (implicated_via_orthology)

MORC1 TPH2

3.94e-0442412DOID:1595 (implicated_via_orthology)
DiseaseHyperbilirubinemia

ABCC2 UGT1A1

3.94e-0442412C0020433
DiseaseKartagener syndrome (is_implicated_in)

DNAI1 DNAH11

3.94e-0442412DOID:0050144 (is_implicated_in)
Diseaseepilepsy (implicated_via_orthology)

SBF1 NOS2 CACNA1B CIT SLC13A1 LRP1 UNC13C

4.02e-041632417DOID:1826 (implicated_via_orthology)
Diseasenasopharynx carcinoma (is_marker_for)

SRC CLPTM1L FLT1 ATM

4.17e-04432414DOID:9261 (is_marker_for)
DiseaseDisproportionate short stature

IFT140 ACP5 EXT2 SMARCAL1 ANKH

4.27e-04772415C0878659
Diseaseesophagus squamous cell carcinoma (is_implicated_in)

CHRNA7 CLPTM1L FAT1 MBD4

4.97e-04452414DOID:3748 (is_implicated_in)
Diseasetype 2 diabetes mellitus (is_implicated_in)

SRC HMOX1 APOM SPHK1 PARL NOS2 APOD

5.36e-041712417DOID:9352 (is_implicated_in)
DiseaseNonsyndromic Deafness

HGF MYO7A ADGRV1 EPS8L2 NARS2

5.39e-04812415C3711374
DiseaseMalignant neoplasm of breast

MAGEA4 ACADM SRC OBSCN MECOM HMOX1 DYSF CLPTM1L BTK NOS2 CNGA2 FLT1 VPS39 TMPRSS6 SMARCAL1 APOC4 AR CHD5 ATM MAP2K7

5.64e-04107424120C0006142
DiseaseMalignant neoplasm of prostate

EPHX1 GALNT3 HMOX1 JAK1 CLPTM1L COL5A1 CREBBP AR CELF2 TIMP4 LRP2 ATM PATJ CDH12

5.92e-0461624114C0376358
DiseaseProstatic Neoplasms

EPHX1 GALNT3 HMOX1 JAK1 CLPTM1L COL5A1 CREBBP AR CELF2 TIMP4 LRP2 ATM PATJ CDH12

5.92e-0461624114C0033578
Diseasesciatic neuropathy (is_implicated_in)

HGF LRP1

6.54e-0452412DOID:11446 (is_implicated_in)
Diseaseplatelet-activating factor measurement

NALF1 IQCM

6.54e-0452412EFO_0801075
Diseaserenal hypertension (implicated_via_orthology)

HMOX1 NOS2

6.54e-0452412DOID:1073 (implicated_via_orthology)
Diseasebilirubin metabolic disorder (implicated_via_orthology)

ABCC2 UGT1A1

6.54e-0452412DOID:2741 (implicated_via_orthology)
Diseaseatopy

ADGRV1 PAK5

6.54e-0452412EFO_0002686
DiseaseLiver Cirrhosis, Experimental

HGF ACP5 ALDH1L1 HMOX1 DYSF FAT1 CLIC2 ABCC2 MMP15 NOS2 GOT1 COL5A1 RCN2 LCP2 CELF2 FYN

6.81e-0477424116C0023893
DiseaseHodgkin Disease

RELN ITK UGT1A1

7.39e-04222413C0019829
DiseaseFibrosis

HMOX1 SPHK1 ATM MAP2K7

7.44e-04502414C0016059
DiseaseCirrhosis

HMOX1 SPHK1 ATM MAP2K7

7.44e-04502414C1623038
Diseasesitting height ratio

MECOM JAK1 NSD1 CRPPA

8.03e-04512414EFO_0007118
Diseaseserum alanine aminotransferase measurement

PSD HLA-DRB1 PKD1L1 ALDH1L1 ITK MMP24 ABCC2 MMP15 FLT1 NEDD4L WWP2 BRD3 FRK SLC13A1 CELF2 PATJ MAP2K7

8.56e-0486924117EFO_0004735
Diseasecognitive disorder (implicated_via_orthology)

CHRNA7 CHRFAM7A

9.75e-0462412DOID:1561 (implicated_via_orthology)
Diseaseleiomyosarcoma (is_marker_for)

FLT1 XRN2

9.75e-0462412DOID:1967 (is_marker_for)
Diseaserheumatoid arthritis (biomarker_via_orthology)

CHRNA7 CHRFAM7A

9.75e-0462412DOID:7148 (biomarker_via_orthology)
Diseaseleukemia

SPHK1 PLK1 AR ATM

1.07e-03552414C0023418
Diseasepre-eclampsia (is_implicated_in)

EPHX1 F5 FLT1

1.08e-03252413DOID:10591 (is_implicated_in)
DiseaseColitis

SRC HMOX1 NOS2

1.08e-03252413C0009319
Diseasebilirubin measurement

UBR1 ZHX3 HLA-DRB1 MYT1 EPX CYB5R3 ABCC2 TMPRSS6 APOC4 UGT1A1 DNAH11

1.10e-0344224111EFO_0004570
DiseaseAlzheimer's disease (is_marker_for)

EPHX1 RELN HMOX1 CHRNA7 NOS2 APOD ATM FYN

1.31e-032572418DOID:10652 (is_marker_for)
Diseaseaspartate aminotransferase measurement

MYO7A HLA-DRB1 OBSCN IPP HMCN2 GLB1 OSBPL6 ABCC2 MMP15 GOT1 MRC1 NEDD4L NSD1 BRD3 FRK CELF2 SOS1

1.31e-0390424117EFO_0004736
Diseasehexanoylglycine measurement

ACADM GLDC

1.36e-0372412EFO_0800233
Diseasetoxic shock syndrome (implicated_via_orthology)

HMOX1 NOS2

1.36e-0372412DOID:14115 (implicated_via_orthology)
Diseaseaflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)

EPHX1 GGTLC3

1.36e-0372412DOID:5022 (biomarker_via_orthology)
Diseasedisease of cellular proliferation (implicated_via_orthology)

JAK1 ATM

1.36e-0372412DOID:14566 (implicated_via_orthology)
Diseasebreast cancer (is_implicated_in)

HLA-DRB1 F5 CYB5R3 UGT1A1 SNW1 ATM

1.50e-031502416DOID:1612 (is_implicated_in)
Diseaseprimary biliary cholangitis (biomarker_via_orthology)

HMOX1 ABCC2 NOS2

1.52e-03282413DOID:12236 (biomarker_via_orthology)
Diseaseneuroblastoma, cutaneous melanoma

CPPED1 HLA-DRB1 FYN

1.52e-03282413EFO_0000389, EFO_0000621
DiseaseAdenocarcinoma of lung (disorder)

CLPTM1L MYO18B FLT1 PAK5 CREBBP ATM SOS1

1.59e-032062417C0152013
DiseaseLung Neoplasms

EPHX1 HMOX1 PTGIS CHRNA7 CLPTM1L NOS2 CWH43 MAP2K7

1.59e-032652418C0024121
DiseaseMalignant neoplasm of lung

EPHX1 HMOX1 PTGIS CHRNA7 CLPTM1L NOS2 CWH43 MAP2K7

1.63e-032662418C0242379
DiseaseDrug-Induced Stevens Johnson Syndrome

PTGIS NOS2 CELF2

1.68e-03292413C1274933
DiseaseMycoplasma-Induced Stevens-Johnson Syndrome

PTGIS NOS2 CELF2

1.68e-03292413C3658301
DiseaseStevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum

PTGIS NOS2 CELF2

1.68e-03292413C3658302
DiseaseToxic Epidermal Necrolysis

PTGIS NOS2 CELF2

1.68e-03292413C0014518
DiseaseAlcoholic Intoxication, Chronic

EPHX1 SPG21 SGIP1 AR ASTN1 FYN CDH8 CDH12

1.70e-032682418C0001973
DiseaseNemaline myopathy

NEB KLHL40

1.80e-0382412cv:C0206157
DiseaseLymphoid leukemia

MECOM CLPTM1L

1.80e-0382412C0023448
Diseasepulmonary hypertension (is_implicated_in)

HMOX1 F5 NOS2

1.86e-03302413DOID:6432 (is_implicated_in)
DiseaseStevens-Johnson Syndrome

PTGIS NOS2 CELF2

1.86e-03302413C0038325
DiseaseDisorder of eye

MYO7A RGS9 ADGRV1 CLN5 CACNA1F B3GLCT RIMS1

1.87e-032122417C0015397
Diseasecarcinoma (implicated_via_orthology)

SRC FLT1 YES1 FYN

1.88e-03642414DOID:305 (implicated_via_orthology)
Diseasebreast carcinoma (is_marker_for)

PARL PLK1 SNW1 ATM

2.10e-03662414DOID:3459 (is_marker_for)
DiseaseSeizures

CHRNA7 GLB1 GLDC ABCC2 NOS2 CACNA1B NARS2

2.18e-032182417C0036572
DiseaseGrand Mal Status Epilepticus

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0311335
DiseasePetit mal status

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0270823
DiseaseComplex Partial Status Epilepticus

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0393734
DiseaseStatus Epilepticus, Subclinical

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0751522
DiseaseSimple Partial Status Epilepticus

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0751524
DiseaseNon-Convulsive Status Epilepticus

SRC HMOX1 ABCC2 NOS2

2.22e-03672414C0751523
DiseaseLymphoma, Non-Hodgkin

EPHX1 HLA-DRB1 CREBBP

2.24e-03322413C0024305
DiseaseSquamous cell carcinoma of lung

MYO18B PLK1 FYN

2.24e-03322413C0149782
DiseaseGeneralized Epilepsy with Febrile Seizures Plus

GABRD ADGRV1

2.30e-0392412C3502809
DiseaseStatus Epilepticus

SRC HMOX1 ABCC2 NOS2

2.35e-03682414C0038220
Diseasesquamous cell lung carcinoma

NEB APOM CLPTM1L ECPAS CATSPER2 RIMS1

2.43e-031652416EFO_0000708
DiseaseChronic Obstructive Airway Disease

EPHX1 HMOX1 NOS2

2.45e-03332413C0024117
Diseasesensorineural hearing loss (is_implicated_in)

MYO7A HLA-DRB1 F5

2.45e-03332413DOID:10003 (is_implicated_in)
DiseaseChronic Airflow Obstruction

EPHX1 HMOX1 NOS2

2.45e-03332413C1527303
Diseaseanorexia nervosa

QSOX1 NALF1 CELSR3 LRP2

2.61e-03702414MONDO_0005351
Diseasemacrovascular complications of diabetes

F5 PDE4DIP

2.86e-03102412EFO_0010977
DiseasePeripheral T-Cell Lymphoma

ATM FYN

2.86e-03102412C0079774
DiseaseCXCL5 measurement

NALF1 BRD3

2.86e-03102412EFO_0009422
DiseaseLeukemia, Myelocytic, Acute

EPHX1 HGF MECOM JAK1 NSD1 CREBBP

3.07e-031732416C0023467
Diseaseesophagus squamous cell carcinoma (is_marker_for)

CHRNA7 CLPTM1L FAT1 ATM

3.19e-03742414DOID:3748 (is_marker_for)
Diseaselung cancer (is_implicated_in)

CHRNA7 CLPTM1L MBD4 XRN2

3.19e-03742414DOID:1324 (is_implicated_in)
Diseaseintraocular pressure measurement

CFAP95 RELN HLA-DRB1 MECOM COL5A1 BRD3 BABAM2 ANKH ELMO3 TANGO2 FYN

3.30e-0350924111EFO_0004695

Protein segments in the cluster

PeptideGeneStartEntry
PELYEIFLSRAKERW

TBC1D12

506

O60347
AYEELRLDSFKDWPR

NAIP

276

Q13075
WYEIEKIPTTFENGR

APOD

46

P05090
EDLIKGFSQWYELTP

ESYT3

866

A0FGR9
AWPFYKPVDAEALEL

BRD3

331

Q15059
DLLLDERSPYWACKG

ADAD2

221

Q8NCV1
QWYFIAGAAPTKEEL

APOM

46

O95445
WSEKELKELFEPYGA

CELF2

51

O95319
PFKDLGNLRYWLEEA

EIF3B

286

P55884
LRRYDPSKEWFLGKA

B3GLCT

146

Q6Y288
WPRDSLFRYFELLEK

CATSPER2

491

Q96P56
IPEREFFVKWAGLSY

CHD5

506

Q8TDI0
WGRSLKYNPVVIDFE

C8A

446

P07357
GYGSWEIDPKDLTFL

BTK

391

Q06187
RKEAEYTLGFWKTFP

ALS2

886

Q96Q42
DPRLKDATYDGRWLS

ALS2

1041

Q96Q42
SRGYDFPAVLRWFAE

EHD2

166

Q9NZN4
KPQWKAYDDVFRGRT

ADGRV1

6086

Q8WXG9
EFLEIGGSKPFRSYW

ARL9

66

Q6T311
LTSAKELPYFEGDFW

CREBBP

1531

Q92793
ANSKVPWEDLRYLFG

DNAH11

4126

Q96DT5
PESPKLEDFYRFSWE

BRPF3

711

Q9ULD4
LRPEVRDFWEKLGSY

ECT2L

366

Q008S8
QLRSAWLGPAYREFE

ANGPTL8

136

Q6UXH0
EYRDQVGTLLPLWKF

DNAI1

311

Q9UI46
GKANWYFLLARSDPD

ACADM

196

P11310
EEPREFWGDIAKEFY

ACSS2

56

Q9NR19
YDDHLRDLGPLTKAW

APOC4

86

P55056
DDEDKLTWKDRFPGY

ANO2

521

Q9NQ90
DWARDIGIPFSYTFE

CPO

296

Q8IVL8
LDEFIRVWAEYDPAA

CACNA1B

1726

Q00975
DDLKWSRLPLAFAYR

CIT

1821

O14578
IKPYGLDWAELSRDL

ASTN1

1266

O14525
WDLVGIPGKRSERFY

CHRNA7

196

P36544
TVLYARDKWLAPDGL

PRMT1

176

Q99873
KDYGLWQLFRTLELP

POLN

416

Q7Z5Q5
VSLEEFLGDYRWDPT

RCN2

206

Q14257
ARFKLWYTLDRAPEA

CYB5R3

231

P00387
YEVGDLIWAKFKRRP

NSD1

321

Q96L73
DVKAWRPALYLAALD

QSOX1

86

O00391
LEGDGPKTYWTRELA

CRABP1

101

P29762
EEIYKLFLAPGARRW

RGS9

351

O75916
KEPDKAFYDWRGFVL

IQCM

186

A0A1B0GVH7
TVKDDRDSPVFWYAP

JAK1

1036

P23458
ELRSFEVYDPLSKRW

IPP

451

Q9Y573
EGSPDLWKVTYKRDL

CRPPA

256

A4D126
DAHLYWSIPSRLDEK

KCNJ9

346

Q92806
NLKDPSYGWEILDEF

MECOM

116

Q03112
GALEDFPARWSFRAY

MORC1

226

Q86VD1
WHRDREAFPKGYDIE

CFAP95

51

Q5VTT2
FLRKYSFDGLDLDWE

CHIT1

126

Q13231
LDESGSYWVSDKRLP

NOS2

806

P35228
EWGPSLDDYDRRPKS

PAK5

256

Q9P286
EGWPALLYKAIDAYA

CACNA1F

1086

O60840
EFKRIWSEYDPGAKG

CACNA1F

1461

O60840
PAWEVRYKIVSGDSE

FAT1

66

Q14517
FWKGLPARIDAAYER

MMP24

421

Q9Y5R2
IDTALRWEPVGKTYF

MMP24

476

Q9Y5R2
ARDLTKIFEAYWFLG

PLD3

241

Q8IV08
FWPAIDDGLRRATYE

PLD3

341

Q8IV08
AEPGRVDTFWYKFLK

EPM2A

76

O95278
VDTFWYKFLKREPGG

EPM2A

81

O95278
YKFLKREPGGELSWE

EPM2A

86

O95278
WDQGLEKPRLDYSEF

FLII

476

Q13045
VYAWVGRASDPDEAK

FLII

1101

Q13045
KAFRESVRPGWEYIG

HHATL

41

Q9HCP6
EFLWGPRALAETSYV

MAGEA4

271

P43358
SDPRSFPLWYEEALK

MAGEA10

321

P43363
ARYEFLWGPRAKAET

MAGEB16

271

A2A368
FESFSDELWKGRLLP

LPAR5

176

Q9H1C0
KLPFKWFDYLRETGS

MBTD1

461

Q05BQ5
WFDYLRETGSIAAPV

MBTD1

466

Q05BQ5
DFTPELGRWLYALLA

GEMIN2

206

O14893
DGKELTISPAYLLWD

GNPTAB

291

Q3T906
GVLFLKLYDGWTEPF

MGAT3

326

Q09327
LLPADRKWGFITVGY

KCTD16

156

Q68DU8
WGREEITYDTPFKRE

LGALS8

86

O00214
IAPIYWALARESGEA

HMCN2

4451

Q8NDA2
GLLPASYDQKDAWVR

PHKA1

31

P46020
GLAIDFPESKLYWIS

LRP1

1746

Q07954
LRDGSYAWEIKDFLV

MESD

161

Q14696
FWRGLPGDISAAYER

MMP15

411

P51511
WAEFQDPLGYIAKIR

KDM5D

21

Q9BY66
DPDYLAAVDKWLGVL

GLB1

151

P16278
YLLGAFESLGKAWPR

ECPAS

1691

Q5VYK3
LAPGDWVFKDSVSYD

ISM2

311

Q6H9L7
DYPSRWTAIVDKIGF

IPO7

121

O95373
KPDYDIRADVWSLGI

MAP2K7

296

O14733
GYPSENVWELDLKRF

PDPR

406

Q8NCN5
EFGDPASSLFRWYKE

PDE12

186

Q6L8Q7
ALARWLPAEYEDGLS

EPX

166

P11678
RLPAGVSWLEFIYSK

CSNKA2IP

676

A0A1B0GTH6
FPSSGRFWKLYIEAE

CSTF3

61

Q12996
PSYRWFKDGKELNRS

NRG2

266

O14511
LAATSEVGDLPWKFY

MYO10

1771

Q9HD67
EAINFATPRWIDYGK

KDM4D

291

Q6B0I6
LPRASAIKALDVYFW

GABRD

301

O14764
GYKRPLTLEDVWEVD

ABCC2

216

Q92887
DRLSFKWGESDPLPY

KLHL40

436

Q2TBA0
WADYGQRPKIERSFL

LRP2

2206

P98164
AVDYDWDPKDIGLSV

LRP2

4086

P98164
LRTDDWAVLPLAGDY

AP5B1

856

Q2VPB7
RIKLENPLDYGSAWA

AR

386

P10275
FPSRDLKDYEAWLGI

HGF

536

P14210
YLLQPLGDFSRAWDV

MON2

1131

Q7Z3U7
DKWSLFGPRSLQKYD

KIAA1191

221

Q96A73
IWTESAFRKLDELYG

RPL4

251

P36578
WKASFLRAGVYPEKD

DNM2

616

P50570
VSNDTYWELRKDPGF

OSBPL6

911

Q9BZF3
YWELRKDPGFSKVDS

OSBPL6

916

Q9BZF3
WDLVGIPGKRSERFY

CHRFAM7A

106

Q494W8
YESGPDEVRAWLEAK

EPS8L2

626

Q9H6S3
YAPGDAVEKWLNDLL

NAT10

471

Q9H0A0
SKWAESGRFYPFLET

IL20RA

121

Q9UHF4
FDRFEGKLSPLWYKI

RELN

1451

P78509
WFGYDVKRAVEEPRL

GGTLC3

146

B5MD39
KVWDFYTEETLAEGP

SBF1

1591

O95248
PKYVGLWDFKSRTDE

PTK6

11

Q13882
SLISWDEPGVDFYSK

PIK3C2B

56

O00750
VSEKGDLDYYWLDPA

RIMS1

556

Q86UR5
WYLDFLAPAKATLGE

GBA

351

P04062
YLDRRLKLSPEWGAA

OBSCN

5661

Q5VST9
AEYWLRKFEADPLPE

PI4K2B

266

Q8TCG2
ERPTFETLRWKLEDY

FRK

476

P42685
DPAIWFEKRLAYTRS

ATM

2841

Q13315
WTDFNKIRVGYPELA

ADAM30

256

Q9UKF2
KEWYRLTEEESAPIG

IGSF3

1091

O75054
LGFAIYWFISRDKEE

EPHX1

11

P07099
YWFISRDKEETLPLE

EPHX1

16

P07099
YRLWEEGIVASLDDP

LACTBL1

91

A8MY62
KDLAKTNELDFWYPG

CPA3

41

P15088
PYAGETLKWDIIFNA

BABAM2

61

Q9NXR7
LYKDVRDLLAGPSWA

ANKZF1

271

Q9H8Y5
TAPDDLIRYAKEWDF

ARV1

126

Q9H2C2
GDILPNADETWYLRA

CD1D

251

P15813
LAKYADPVADLLDRW

CTDSPL

171

O15194
AFAGRYAFRIWKPLE

DNAJC15

51

Q9Y5T4
FPKVEYIARAGWTRD

DPP9

346

Q86TI2
ECFYGWLEPLLARIA

GALNT3

281

Q14435
DDYITEKFWRPLKLG

FUT10

286

Q6P4F1
KWTAPEAALYGRFTI

FYN

431

P06241
VPDYERDKLLLANWG

POLQ

61

O75417
FRAVTELGRPDAEYW

HLA-DRB1

76

P01911
YWDAEKRGLDLQGFL

GOT1

161

P17174
GWLTEIRAVYPAFDK

ANKH

291

Q9HCJ1
DYPLFRGINLSDGKW

COL5A1

151

P20908
ESEWKGPFYFILGAD

CPPED1

26

Q9BRF8
PSKREFYLWTDGLSA

ELMO3

646

Q96BJ8
EYRRFLDWGAPNAKV

CRYGB

151

P07316
WELLTGEIPYKDVDS

MAP3K12

301

Q12852
WRDVSELLKPLGLYD

MBD4

496

O95243
LDSWGDPKAAYRLEQ

HOXC10

76

Q9NYD6
VPLGDDFRYDKPQEW

MAN2A2

421

P49641
KAALEQDLAFWYGPR

HMOX1

86

P09601
IDPDDFPLLVAYWEK

CASQ2

306

O14958
DYLTDWGPRFKVLAD

CDH12

766

P55289
TELGPEEVRWFYKED

DDHD1

161

Q8NEL9
LSDWGPRFKRLGELY

CDH8

776

P55286
EAFLYKSLPLWDGLC

CENPI

436

Q92674
KDVDGNDLLSYWPAL

CELSR3

2941

Q9NYQ7
KDWVPDAAGTSLYVR

BCAT2

156

O15382
EFDARWVTYFNKPDI

COX5A

51

P20674
VTYDDKAEAGPFSWI

ERVFC1

216

P60507
GEIVAFDYSPLITWK

SLC13A1

411

Q9BZW2
YLRKWLLLSDPDDFS

DYSF

316

O75923
RFWDIERGENYILSP

IFT140

301

Q96RY7
KSKWEGNYLFPRELF

NOC4L

136

Q9BVI4
KETIPLEFEWYFGED

PKD1L1

531

Q8TDX9
RDFDIPAEFSGVWRY

CLIC2

201

O15247
IIWEEFTPEEGKGYR

CSF2RA

376

P15509
SAFLKAWVYRPGEDT

PPP1R15A

426

O75807
DESGLWVIYPAVDDR

OLFML2A

526

Q68BL7
LRYGKWVIDPSELTF

ITK

351

Q08881
YFDGIKADWLDSIRP

PARL

131

Q9H300
GLRPEKYFWTGLSDI

MRC1

556

P22897
WKDFYIVEPLAFEGT

HEXA

431

P06865
KEVSAAIWPFRFGYD

CWH43

426

Q9H720
DEEETKYEIFPWALG

SPDYA

136

Q5MJ70
WTAPEAALYGRFTIK

SRC

431

P12931
YERGISLFKWPNVSD

XAB2

541

Q9HCS7
VRADLRDNYSPGWKF

EPRS1

1341

P07814
LLDASWYLPKLGRDA

MPST

31

P25325
WYLPKLGRDARREFE

MPST

36

P25325
WYAKGALETEDPALI

SEL1L3

716

Q68CR1
ARAKWEFFYGSLDPP

PSD

236

A5PKW4
SQIKASEFLGYWEPR

F5

1921

P12259
RFEPTWEELELYKDG

POFUT2

351

Q9Y2G5
YFLAGRDKSQRLWEP

MRGPRF

291

Q96AM1
IWDRSSPEVKEAYGE

RDH16

226

O75452
SIPWLGYALDFGKDA

PTGIS

36

Q16647
PEWGADLRTEHEKYL

NARS2

341

Q96I59
EFEFWYPVDLRVSGK

LARS1

661

Q9P2J5
RDRGIFGIESWPDYE

TAF1B

261

Q53T94
DGIDYNPWVEFVKLA

KYAT1

11

Q16773
YLVAKGTADDYLWPL

SMARCAL1

831

Q9NZC9
LGPRKDYWDFLCTAL

RUFY4

61

Q6ZNE9
VVEWAAKDPYGFLTT

SMIM15

11

Q7Z3B0
DDDSKIWSLYDAGPR

SPG21

26

Q9NZD8
VFPEGWDKRYCLDSL

PMM1

191

Q92871
LPYEFFSEENAPKWR

SOS1

6

Q07889
GIPEERLWISYFDGD

AARS2

161

Q5JTZ9
RLWISYFDGDPKAGL

AARS2

166

Q5JTZ9
AEKDGVPVFKYSRWR

ALDH1L1

46

O75891
RLQAPVWEFKYGDLL

CLN5

96

O75503
WLYPVDKRRVNEFGE

CLPTM1L

511

Q96KA5
DYGKRSLPGVNDFWL

CLEC3A

116

O75596
KKFELFVLDPAGDWY

CNGA2

126

Q16280
WSKFYRSDPRIALGK

C10orf120

61

Q5SQS8
EEWKSLDPGQRALYR

ZNF610

36

Q8N9Z0
LAYAAGAFRWLEPSE

RHBDD3

176

Q9Y3P4
DPDEWRLEKYVGALE

USE1

26

Q9NZ43
IVTPEDALYGWKFTR

VNN2

76

O95498
DALYGWKFTRETVFP

VNN2

81

O95498
ADVEGFKDPALYTSW

TUBD1

356

Q9UJT1
VAPLEWLRYFDEKEL

WWP2

731

O00308
PAFKDAVPEYSLWFE

UNC13C

1676

Q8NB66
ARVYWDPPLVKDSAD

SRPX2

201

O60687
ELKSRWENLLGPDYE

PATJ

526

Q8NI35
EQPSLVWFDRGKFYL

SGIP1

526

Q9BQI5
FDWLYARLAEKFPVI

SNX18

316

Q96RF0
WRKEDGELPTGRYEI

ROBO3

291

Q96MS0
EFWDTAPAFEGRKEI

UBTD2

56

Q8WUN7
WRKPGAVSFADVAVY

ZNF747

31

Q9BV97
KYAWQGVALLPFVDE

XRN2

641

Q9H0D6
ERTLLKEDPAYWFLS

SUGP2

606

Q8IX01
DSYILPFSEVLDWKR

EXT2

346

Q93063
ASVWLFRSDFVKDYP

UGT1A1

251

P22309
WYLFGEDPDICLEKL

UBR1

76

Q8IWV7
WPVDETKRGRDLGAY

UQCC2

16

Q9BRT2
EDVFSDRSLRKVPWY

ACP5

91

P13686
SWYRGHLPLRKEFVD

TIMP4

206

Q99727
DIKRKLPWFPSDFYD

SLC4A5

501

Q9BY07
YRKGWIPRLLEDFGD

SNW1

46

Q13573
SDYEGFATLIREWPG

VPS41

471

P49754
KYWARRGFSLDSAVP

TPH2

11

Q8IWU9
SDPFSWKLPSLDYER

MYO18B

2421

Q8IUG5
GPEFYLENISLSWEK

TEX13A

31

Q9BXU3
YLLSWKESRGNIEPD

TTC29

426

Q8NA56
DIPFYFSREEWGTLD

ZNF213

206

O14771
FTRDDPYSILEELWK

ZNF484

106

Q5JVG2
WGFIADVDLESEKYR

SPHK1

171

Q9NYA1
WFVDTAERYALAGRP

WDR24

411

Q96S15
AERLWEYGFLRTPEQ

ZSCAN29

446

Q8IWY8
DPFWDLSLPIAKRGY

USP2

436

O75604
ERLPYDASKWEFARE

FLT1

811

P17948
PEVVRWFGDSRYALK

ZHX3

806

Q9H4I2
DSLGYAFSKPDLITW

ZNF425

46

Q6IV72
TARDGPGVLWIFLDY

SLFN5

671

Q08AF3
TVPSLDYGLALWFDA

TMPRSS6

371

Q8IU80
RDEFYSRPSKLADFW

TANGO2

26

Q6ICL3
SYSVWVLRDFPEDGL

VPS39

556

Q96JC1
IKWTAPEAALYGRFT

YES1

436

P07947
EGDELARLPYLRTWF

PLK1

501

P53350
LKAGPFWRLGVYIDF

TRIM16L

271

Q309B1
RAEGSLKIFISAPYW

VPS13D

3271

Q5THJ4
KFWPTIARIDDIYGD

GLDC

981

P23378
WAEFRDPLGYIAKIR

KDM5C

21

P41229
EVLGWDPDSLADYFK

LCP2

11

Q13094
YDDGLKIWLAAPREN

NALF1

11

B1AL88
EDVVSYARFKWPLLF

MYO7A

1456

Q13402
LAEELRSASWPGKYD

PDE4DIP

1461

Q5VU43
DEWDRPLDYTKPSRL

MYT1

726

Q01538
WEEALKKGYDLPVDA

NEB

2276

P20929
ARLWIEFESEKGLDY

NEDD4L

646

Q96PU5